In the drug sensitivity analysis, we found higher SOX13 expression in BC indicates a higher IC50 value for most drugs in the GDSC2 database, which shows the measurement of SOX13 expression level may act as a reliable indicator for clinical therapy. Here, SOX13 is linked to breast cancer.